tm
Seeing Is Believing
tm
Seeing Is Believing
INKT is currently covered by 3 analysts with an average price target of $14.73. This is a potential upside of $5.57 (60.81%) from yesterday's end of day stock price of $9.16.
Mink Therapeutics's activity chart (see below) currently has 3 price targets and 11 ratings on display. The stock rating distribution of INKT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 308.75 days.
Highest price target for INKT is $9, Lowest price target is $9, average price target is $14.73.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 15-Nov-2024. First documented stock forecast 09-Nov-2021.
Currently out of the existing stock ratings of INKT, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$9
$-0.16 (-1.75%)
$9
2 months 17 days ago
(15-Nov-2024)
7/7 (100%)
$8.27 (1132.88%)
462
Buy
$8
$-1.16 (-12.66%)
$26
1 years 10 months 10 days ago
(22-Mar-2023)
1/2 (50%)
$5.91 (282.78%)
681
Buy
$3
$-6.16 (-67.25%)
$30
1 years 10 months 10 days ago
(22-Mar-2023)
1/2 (50%)
$0.91 (43.54%)
92
Buy
$10
2 years 8 months 21 days ago
(11-May-2022)
0/2 (0%)
$7.18 (254.61%)
What is INKT (Mink Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on INKT (Mink Therapeutics) with a proven track record?
Which analyst has the current lower performing score on INKT (Mink Therapeutics) with a proven track record?
Which analyst has the most public recommendations on INKT (Mink Therapeutics)?
Which analyst is the currently most bullish on INKT (Mink Therapeutics)?
Which analyst is the currently most reserved on INKT (Mink Therapeutics)?
